MedPath

Shanghai Jiaotong Medical University Attached Ruijin Hospital

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

ARTA-based Chemo-free Bridging/Maintenance Therapy in CAR-T Treatment for High-Risk R/R B-NHL Ineligible for HDCT and ASCT

Phase 2
Not yet recruiting
Conditions
B-cell Non Hodgkin Lymphoma
Interventions
Radiation: radiotherapy
Drug: CAR-T
Drug: PD-1 inhibitor
First Posted Date
2024-10-17
Last Posted Date
2024-11-01
Lead Sponsor
Ruijin Hospital
Target Recruit Count
35
Registration Number
NCT06646666
Locations
🇨🇳

Department of Hematology, Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Gastrointestinal Malignancies

Recruiting
Conditions
Gastrointestinal Malignancies
First Posted Date
2024-10-16
Last Posted Date
2024-12-11
Lead Sponsor
Ruijin Hospital
Target Recruit Count
40
Registration Number
NCT06644274
Locations
🇨🇳

Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine, Shanghai, Shanghai, China

The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Advanced Soft Tissue Sarcomas

Recruiting
Conditions
Advanced Soft Tissue Sarcomas
First Posted Date
2024-10-16
Last Posted Date
2024-12-13
Lead Sponsor
Ruijin Hospital
Target Recruit Count
40
Registration Number
NCT06644287
Locations
🇨🇳

Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine, Shanghai, Shanghai, China

Respiratory Virome Diversity and Baseline Immunity in Healthy Individuals in Shanghai

Recruiting
Conditions
Health Personnel
First Posted Date
2024-10-15
Last Posted Date
2024-10-29
Lead Sponsor
Ruijin Hospital
Target Recruit Count
300
Registration Number
NCT06641856
Locations
🇨🇳

Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China

Quantitative Ultrasound Assessment of Abdominal Cavity Space

Not yet recruiting
Conditions
Sepsis
MODS
Shock
First Posted Date
2024-10-10
Last Posted Date
2024-10-10
Lead Sponsor
Ruijin Hospital
Target Recruit Count
125
Registration Number
NCT06634732
Locations
🇨🇳

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China

The Application Value of 68Ga-grazytracer PET in Immunotherapy for Stage III Non-small-cell Lung Cancer

Recruiting
Conditions
Carcinoma, Non-Small-Cell Lung
PET / CT
Neoadjuvant Immunotherapy
First Posted Date
2024-10-02
Last Posted Date
2024-10-02
Lead Sponsor
Ruijin Hospital
Target Recruit Count
30
Registration Number
NCT06623487
Locations
🇨🇳

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China

First-in-Human Pilot Study of Epicardial Circular RNA-HM2002 Injection in CABG for Ischemic Heart Failure

Early Phase 1
Active, not recruiting
Conditions
Ischaemic Heart Disease
Heart Failure
Interventions
Drug: HM2002 injection
First Posted Date
2024-10-01
Last Posted Date
2025-04-02
Lead Sponsor
Ruijin Hospital
Target Recruit Count
3
Registration Number
NCT06621576
Locations
🇨🇳

Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China

68Ga-grazytracer PET Assists in Diagnosing Pseudoprogression Following Immunotherapy in Lung Cancer.

Recruiting
Conditions
PET / CT
Lung Carcinoma
Immunotherapy
First Posted Date
2024-09-23
Last Posted Date
2024-09-23
Lead Sponsor
Ruijin Hospital
Target Recruit Count
30
Registration Number
NCT06608160
Locations
🇨🇳

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China

Autologous Hematopoietic Stem Cell Boost Study After CAR-T Therapy

Phase 2
Recruiting
Conditions
Diffuse Large B Cell Lymphoma
Interventions
Drug: autologous hematopoietic stem cell
First Posted Date
2024-09-19
Last Posted Date
2024-10-23
Lead Sponsor
Ruijin Hospital
Target Recruit Count
18
Registration Number
NCT06589089
Locations
🇨🇳

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

PET/CT-Based Image Analysis and Machine Learning of Hypermetabolic Pulmonary Lesions

Active, not recruiting
Conditions
Lung Cancers
Pulmonary Lymphomas
Pulmonary Metastases
Benign Pulmonary Diseases
Interventions
Other: Observe the medical images
Other: Feature extraction
First Posted Date
2024-09-19
Last Posted Date
2024-12-19
Lead Sponsor
Ruijin Hospital
Target Recruit Count
600
Registration Number
NCT06602674
Locations
🇨🇳

Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine, Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath